Bustamante, Jennylyn .

HRN: 13-15-87  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2024
CEFUROXIME 500MG (TAB)
01/10/2024
01/17/2024
ORAL
500mg
BID
Urinary Tract Infection
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: